Market Research Report
Global Insulin Pens Market 2019-2023
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||756666|
|Published||Content info||107 Pages
Delivery time: 1-2 business days
|Global Insulin Pens Market 2019-2023|
|Published: November 12, 2018||Content info: 107 Pages||
The increasing focus on development of smart insulin pens for type 2 diabetes is likely to drive growth in the market. Companies are striving to grow in the market by incorporating advanced technologies into their products and services. Technavio's analysts have predicted that the insulin pens market will register a CAGR of close to 9% by 2023.
Growing incidence of diabetes have increased the demand for insulin pens in the market.
Product recalls pose as a biggest threat to the market. Regulatory bodies and companies recalling products can impact the sales and a company's brand image.
For the detailed list of factors that will drive and challenge the growth of the insulin pens market during the 2019-2023, view our report.
The market appears to be concentrated and with the presence of few companies including BD and Eli Lilly the competitive environment is quite intense. Factors such as the increasing focus on development of smart insulin pens and the incidences of diabetes, will provide considerable growth opportunities to insulin pens manufactures. BD, Eli Lilly, Sanofi, and Novo Nordisk are some of the major companies covered in this report.
'With the presence of a considerable number of companies, this market appears to be concentrated. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.'